Piscataway, NJ, May 16, 2016– Camber Pharmaceuticals announces that it has launched Methylphenidate, USP 5, 10 and 20 mg tablets. The drug is the generic version of Ritalin® tablets. Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Methylphenidate is available in 100 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
